HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A potential therapeutic strategy for capillary hemangioma with new anti-vascular endothelial growth factor (anti-VEGF) agents.

AuthorsMorsal Mehriar, Abbas Attarzadeh, Mahsa Naseri, Naser Owji, Sirus Siyoofi, Mahnaz Mosallaei
JournalMedical hypotheses (Med Hypotheses) Vol. 69 Issue 4 Pg. 951 ( 2007) ISSN: 0306-9877 [Print] United States
PMID17408872 (Publication Type: Letter)
Chemical References
  • Antibodies, Monoclonal
  • Vascular Endothelial Growth Factor A
  • Receptors, Vascular Endothelial Growth Factor
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Hemangioma, Capillary (drug therapy)
  • Humans
  • Infant
  • Infant, Newborn
  • Receptors, Vascular Endothelial Growth Factor (immunology)
  • Vascular Endothelial Growth Factor A (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: